Cost and outcome analysis of kidney transplantation
Subtitle: the implications of initial immunosuppressive protocol and diabetes : final report
By: Roger W. Evans, Ph.D. (Co-Principal Investigator), Diane L. Manninen, Ph.D. (Co-Principal Investigator), Claudia Thompson, B.S.
Contributors: Manninen, Diane L. (Diane Lynn); Thompson, Claudia; Eggers, Paul W.; United States. Health Care Financing Administration; Battelle Human Affairs Research Centers. Health and Population Research Center
Publisher: Battelle Human Affairs Research Centers, Health and Population Research Center
Published: 1989
Place of publication: Seattle, Washington
Language: eng
Subjects: Evaluation; Cyclosporine; Immunotherapy; Outcome assessment (Medical care); Chronic renal failure; Patients; Transplantation; Medicare; Kidneys; Rehabilitation; Costs
Notes: "This research was supported by the Health Care Financing Administration, Cooperative Agreement 14-C-98564/0."

"August 1989."

"BHARC-100/89/031."

"Federal Project Officer: Paul Eggers, Ph.D."

Includes bibliographical references.
Table of contents: title: v. 1. ch. 1. Introduction ; ch. 2. Data collection methodology ; ch. 3. Clinical immunosuppression : a review ; ch. 4. Sociodemographic and clinical characteristics of kidney transplant recipients ; ch. 5. Operative procedures and immunosuppressive drug administration ; ch. 6. Graft and patient survival ; ch. 7. Posttransplant clinical course of kidney transplant recipients ; ch. 8. Employment, work disability, and income support program participation ; ch. 9. The functional limitations of kidney transplant recipients ; ch. 10. The health status of kidney transplant recipients ; ch. 11. The subjective quality of life of kidney transplant recipients; title: v. 2. ch. 12. Hospital charges ; ch. 13. The cost of immunosuppression and coverage of immunosuppressive drugs for kidney transplant recipients under the Medicare Catastrophic Coverage Act ; ch. 14. Donor characteristics ; ch. 15 United States public opinion concerning the procurement and distribution of donor organs ; ch. 16. Money matters : should ability to pay ever be a consideration in gaining access to transplantation? ; ch. 17. The designation of centers for specialized health care services ; ch. 18. Some ethical issues in transplantation ; ch. 19. Other aspects of transplantation and a review of recent activities ; ch. 20. Summary and conclusions ; References ; Appendices.